MEI Total Assets from 2010 to 2025

MEIP Stock

USD 2.30 0.01 0.43%

MEI Pharma Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to grow to about 62.7 M this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2002-06-30

Previous Quarter

27.8 M

Current Value

24.4 M

Quarterly Volatility

57.8 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check MEI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma's main balance sheet or income statement drivers, such as Interest Expense of 310.3 K, Selling General Administrative of 28.1 M or Total Revenue of 78.8 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.49 or PTB Ratio of 0.63. MEI financial statements analysis is a perfect complement when working with MEI Pharma Valuation or Volatility modules.

Check out the analysis of MEI Pharma Correlation against competitors.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

Latest MEI Pharma's Total Assets Growth Pattern

Below is the plot of the Total Assets of MEI Pharma over the last few years. Total assets refers to the total amount of MEI Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MEI Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. MEI Pharma's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEI Pharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 41.38 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

MEI Total Assets Regression Statistics

	Arithmetic Mean	80,687,954
	Geometric Mean	57,723,012
	Coefficient Of Variation	75.39
	Mean Deviation	48,208,410
	Median	62,725,013
	Standard Deviation	60,831,508
	Sample Variance	3700.5T
	Range	203.4M
	R-Value	0.45
	Mean Square Error	3167.1T
	R-Squared	0.20
	Significance	0.08
	Slope	5,731,327
	Total Sum of Squares	55507.1T

MEI Total Assets History

	2025	62.7 M
	2024	47.6 M
	2023	41.4 M
	2022	120.8 M
	2021	177.8 M
	2020	174.1 M
	2019	209.7 M

Other Fundumenentals of MEI Pharma

Intangibles To Total Assets

MEI Pharma Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Total Liab	Total Current Assets	Retained Earnings	Short Term Investments	Property Plant Equipment	Net Tangible Assets	Good Will	Capital Surpluse	Intangible Assets	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Net Receivables	Short Term Debt
Total Assets		0.65	0.22	0.71	0.96	1.0	-0.57	0.98	0.21	0.65	0.12	0.66	0.12	0.79	0.3	0.94	0.83	-0.15
Total Stockholder Equity	0.65		-0.2	0.2	0.42	0.68	-0.27	0.63	-0.16	0.96	0.58	0.44	0.58	0.49	0.52	0.55	0.61	-0.24
Net Debt	0.22	-0.2		0.48	0.31	0.2	-0.55	0.34	0.57	-0.19	-0.49	0.51	-0.49	0.18	-0.4	0.12	0.08	0.39
Accounts Payable	0.71	0.2	0.48		0.77	0.68	-0.78	0.69	0.57	0.18	-0.01	0.77	-0.01	0.39	-0.32	0.55	0.37	0.22
Total Liab	0.96	0.42	0.31	0.77		0.95	-0.56	0.93	0.26	0.42	-0.08	0.62	-0.08	0.78	0.2	0.94	0.77	-0.11
Total Current Assets	1.0	0.68	0.2	0.68	0.95		-0.55	0.98	0.18	0.68	0.13	0.65	0.13	0.81	0.34	0.94	0.85	-0.17
Retained Earnings	-0.57	-0.27	-0.55	-0.78	-0.56	-0.55		-0.6	-0.84	-0.26	-0.18	-0.93	-0.18	-0.24	0.47	-0.33	-0.27	-0.61
Short Term Investments	0.98	0.63	0.34	0.69	0.93	0.98	-0.6		0.27	0.65	0.06	0.68	0.06	0.79	0.28	0.9	0.81	-0.12
Property Plant Equipment	0.21	-0.16	0.57	0.57	0.26	0.18	-0.84	0.27		-0.13	0.03	0.7	0.03	-0.03	-0.71	-0.02	-0.05	0.77
Net Tangible Assets	0.65	0.96	-0.19	0.18	0.42	0.68	-0.26	0.65	-0.13		0.61	0.36	0.61	0.48	0.52	0.53	0.59	-0.32
Good Will	0.12	0.58	-0.49	-0.01	-0.08	0.13	-0.18	0.06	0.03	0.61		0.19	1.0	-0.08	-0.03	-0.09	-0.08	0.02
Capital Surpluse	0.66	0.44	0.51	0.77	0.62	0.65	-0.93	0.68	0.7	0.36	0.19		0.19	0.39	-0.33	0.44	0.41	0.56
Intangible Assets	0.12	0.58	-0.49	-0.01	-0.08	0.13	-0.18	0.06	0.03	0.61	1.0	0.19		-0.08	-0.03	-0.09	-0.08	0.02
Current Deferred Revenue	0.79	0.49	0.18	0.39	0.78	0.81	-0.24	0.79	-0.03	0.48	-0.08	0.39	-0.08		0.48	0.84	0.87	-0.32
Net Invested Capital	0.3	0.52	-0.4	-0.32	0.2	0.34	0.47	0.28	-0.71	0.52	-0.03	-0.33	-0.03	0.48		0.52	0.65	-0.76
Net Working Capital	0.94	0.55	0.12	0.55	0.94	0.94	-0.33	0.9	-0.02	0.53	-0.09	0.44	-0.09	0.84	0.52		0.9	-0.33
Net Receivables	0.83	0.61	0.08	0.37	0.77	0.85	-0.27	0.81	-0.05	0.59	-0.08	0.41	-0.08	0.87	0.65	0.9		-0.3
Short Term Debt	-0.15	-0.24	0.39	0.22	-0.11	-0.17	-0.61	-0.12	0.77	-0.32	0.02	0.56	0.02	-0.32	-0.76	-0.33	-0.3

Click cells to compare fundamentals

About MEI Pharma Financial Statements

MEI Pharma shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although MEI Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in MEI Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on MEI Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	47.6 M	62.7 M

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC